Samsca
Samsca is an oral selective vasopressin antagonist for the treatment of patients with clinically significant hypervolemic and euvolemic hyponatremia including patients with heart failure, cirrhosis and the syndrome of inappropriate anti-diuretic hormone (SIADH).